{"id":294047,"date":"2026-10-08T10:50:11","date_gmt":"2026-10-08T05:20:11","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=294047"},"modified":"2026-10-08T10:50:11","modified_gmt":"2026-10-08T05:20:11","slug":"custom-synthesis-chemical-stocks-strong-roadmap","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/custom-synthesis-chemical-stocks-strong-roadmap\/","title":{"rendered":"3 Custom Synthesis Chemical Stocks With a Strong Future Roadmap: Aarti Industries, Anupam Rasayan India and Tatva Chintan Pharma Chem"},"content":{"rendered":"

Aarti Industries Rs 491.25, P\/E 33.51. Anupam Rasayan Rs 1,165.10, P\/E 59.02. Tatva Chintan Rs 1,991.20, P\/E 90.78. Closing prices of 7 Oct 2026.<\/em><\/p>\n

\n

Quick Answer<\/strong><\/p>\n

Custom synthesis chemical stocks with the clearest long-term roadmaps today include Aarti Industries in benzene-based specialty chemicals and intermediates, Anupam Rasayan India in custom synthesis of specialty chemicals for global agro, pharma and material science clients and Tatva Chintan Pharma Chem in phase transfer catalysts and specialty chemicals. FY26 revenue growth was 13.8% at Aarti Industries, 64.6% at Anupam Rasayan and 32.3% at Tatva Chintan. P\/E stands at 33.51 for Aarti Industries (industry 36.85), 59.02 for Anupam Rasayan (industry 36.85) and 90.78 for Tatva Chintan (industry 36.85). Demand cycles, input costs and valuation decide how much of that growth the market keeps paying for, so each company’s risks need equal attention.<\/p>\n<\/p><\/div>\n

Custom synthesis chemical stocks give investors exposure to firms that make specialty intermediates for agro, pharma and material science clients. Results depend on long-term contracts, plant use and raw material costs, which is why customer ties matter as much as headline growth.<\/p>\n

This list covers three agro and pharma intermediate stocks: Aarti Industries for benzene-based specialty chemicals and intermediates, Anupam Rasayan India for custom synthesis of specialty chemicals for global agro, pharma and material science clients and Tatva Chintan Pharma Chem for phase transfer catalysts and specialty chemicals. Every figure comes from the latest reported financials and the 7 October 2026 market close. Companies without complete current figures were left out.<\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n